PMC:7650537 / 30872-31479 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T186","span":{"begin":34,"end":37},"obj":"Body_part"},{"id":"T187","span":{"begin":158,"end":161},"obj":"Body_part"},{"id":"T188","span":{"begin":388,"end":391},"obj":"Body_part"},{"id":"T189","span":{"begin":447,"end":449},"obj":"Body_part"},{"id":"T191","span":{"begin":454,"end":456},"obj":"Body_part"}],"attributes":[{"id":"A186","pred":"fma_id","subj":"T186","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A187","pred":"fma_id","subj":"T187","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A188","pred":"fma_id","subj":"T188","obj":"http://purl.org/sig/ont/fma/fma62872"},{"id":"A189","pred":"fma_id","subj":"T189","obj":"http://purl.org/sig/ont/fma/fma13444"},{"id":"A190","pred":"fma_id","subj":"T189","obj":"http://purl.org/sig/ont/fma/fma68614"},{"id":"A191","pred":"fma_id","subj":"T191","obj":"http://purl.org/sig/ont/fma/fma13443"},{"id":"A192","pred":"fma_id","subj":"T191","obj":"http://purl.org/sig/ont/fma/fma68615"}],"text":"Figure 3 Detection of SARS-CoV-2 IgG/total antibodies in twelve routine samples. A signal (S)/cut-off (CO) value ≥1 is considered as positive for SARS-CoV-2 IgG/total antibodies. The samples #4 to #6 were obtained from family members of the SARS-CoV-2-infected patient no. 14 (sample #22 in Figure 1). Results of the plaque reduction neutralization test (PRNT, Figure S2), the ViraChip® IgG test (Viramed, VM), and of both recomLine assays (blot v1 and v2) are listed in the table. p, positive; n, negative; and nd, not determined. For better clarity, positive test results are printed in red in the table."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T148","span":{"begin":23,"end":31},"obj":"Disease"},{"id":"T149","span":{"begin":147,"end":155},"obj":"Disease"},{"id":"T150","span":{"begin":242,"end":250},"obj":"Disease"},{"id":"T151","span":{"begin":513,"end":515},"obj":"Disease"}],"attributes":[{"id":"A148","pred":"mondo_id","subj":"T148","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A149","pred":"mondo_id","subj":"T149","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A150","pred":"mondo_id","subj":"T150","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A151","pred":"mondo_id","subj":"T151","obj":"http://purl.obolibrary.org/obo/MONDO_0010691"}],"text":"Figure 3 Detection of SARS-CoV-2 IgG/total antibodies in twelve routine samples. A signal (S)/cut-off (CO) value ≥1 is considered as positive for SARS-CoV-2 IgG/total antibodies. The samples #4 to #6 were obtained from family members of the SARS-CoV-2-infected patient no. 14 (sample #22 in Figure 1). Results of the plaque reduction neutralization test (PRNT, Figure S2), the ViraChip® IgG test (Viramed, VM), and of both recomLine assays (blot v1 and v2) are listed in the table. p, positive; n, negative; and nd, not determined. For better clarity, positive test results are printed in red in the table."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T244","span":{"begin":82,"end":83},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T245","span":{"begin":84,"end":90},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T246","span":{"begin":286,"end":288},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"},{"id":"T247","span":{"begin":350,"end":354},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T248","span":{"begin":369,"end":371},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T249","span":{"begin":369,"end":371},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"},{"id":"T250","span":{"begin":392,"end":396},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"},{"id":"T251","span":{"begin":562,"end":566},"obj":"http://purl.obolibrary.org/obo/UBERON_0000473"}],"text":"Figure 3 Detection of SARS-CoV-2 IgG/total antibodies in twelve routine samples. A signal (S)/cut-off (CO) value ≥1 is considered as positive for SARS-CoV-2 IgG/total antibodies. The samples #4 to #6 were obtained from family members of the SARS-CoV-2-infected patient no. 14 (sample #22 in Figure 1). Results of the plaque reduction neutralization test (PRNT, Figure S2), the ViraChip® IgG test (Viramed, VM), and of both recomLine assays (blot v1 and v2) are listed in the table. p, positive; n, negative; and nd, not determined. For better clarity, positive test results are printed in red in the table."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T98","span":{"begin":104,"end":106},"obj":"Chemical"},{"id":"T99","span":{"begin":369,"end":371},"obj":"Chemical"},{"id":"T100","span":{"begin":407,"end":409},"obj":"Chemical"}],"attributes":[{"id":"A98","pred":"chebi_id","subj":"T98","obj":"http://purl.obolibrary.org/obo/CHEBI_17245"},{"id":"A99","pred":"chebi_id","subj":"T99","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"},{"id":"A100","pred":"chebi_id","subj":"T100","obj":"http://purl.obolibrary.org/obo/CHEBI_75015"}],"text":"Figure 3 Detection of SARS-CoV-2 IgG/total antibodies in twelve routine samples. A signal (S)/cut-off (CO) value ≥1 is considered as positive for SARS-CoV-2 IgG/total antibodies. The samples #4 to #6 were obtained from family members of the SARS-CoV-2-infected patient no. 14 (sample #22 in Figure 1). Results of the plaque reduction neutralization test (PRNT, Figure S2), the ViraChip® IgG test (Viramed, VM), and of both recomLine assays (blot v1 and v2) are listed in the table. p, positive; n, negative; and nd, not determined. For better clarity, positive test results are printed in red in the table."}

{"project":"LitCovid-sentences","denotations":[{"id":"T248","span":{"begin":0,"end":81},"obj":"Sentence"},{"id":"T249","span":{"begin":82,"end":179},"obj":"Sentence"},{"id":"T250","span":{"begin":180,"end":273},"obj":"Sentence"},{"id":"T251","span":{"begin":274,"end":302},"obj":"Sentence"},{"id":"T252","span":{"begin":303,"end":532},"obj":"Sentence"},{"id":"T253","span":{"begin":533,"end":607},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Figure 3 Detection of SARS-CoV-2 IgG/total antibodies in twelve routine samples. A signal (S)/cut-off (CO) value ≥1 is considered as positive for SARS-CoV-2 IgG/total antibodies. The samples #4 to #6 were obtained from family members of the SARS-CoV-2-infected patient no. 14 (sample #22 in Figure 1). Results of the plaque reduction neutralization test (PRNT, Figure S2), the ViraChip® IgG test (Viramed, VM), and of both recomLine assays (blot v1 and v2) are listed in the table. p, positive; n, negative; and nd, not determined. For better clarity, positive test results are printed in red in the table."}

{"project":"LitCovid-PubTator","denotations":[{"id":"640","span":{"begin":447,"end":456},"obj":"Gene"},{"id":"641","span":{"begin":92,"end":93},"obj":"Gene"},{"id":"642","span":{"begin":262,"end":269},"obj":"Species"},{"id":"643","span":{"begin":23,"end":33},"obj":"Species"},{"id":"644","span":{"begin":147,"end":157},"obj":"Species"},{"id":"645","span":{"begin":242,"end":261},"obj":"Disease"}],"attributes":[{"id":"A640","pred":"tao:has_database_id","subj":"640","obj":"Gene:28299"},{"id":"A641","pred":"tao:has_database_id","subj":"641","obj":"Gene:43740568"},{"id":"A642","pred":"tao:has_database_id","subj":"642","obj":"Tax:9606"},{"id":"A643","pred":"tao:has_database_id","subj":"643","obj":"Tax:2697049"},{"id":"A644","pred":"tao:has_database_id","subj":"644","obj":"Tax:2697049"},{"id":"A645","pred":"tao:has_database_id","subj":"645","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Figure 3 Detection of SARS-CoV-2 IgG/total antibodies in twelve routine samples. A signal (S)/cut-off (CO) value ≥1 is considered as positive for SARS-CoV-2 IgG/total antibodies. The samples #4 to #6 were obtained from family members of the SARS-CoV-2-infected patient no. 14 (sample #22 in Figure 1). Results of the plaque reduction neutralization test (PRNT, Figure S2), the ViraChip® IgG test (Viramed, VM), and of both recomLine assays (blot v1 and v2) are listed in the table. p, positive; n, negative; and nd, not determined. For better clarity, positive test results are printed in red in the table."}